Sixth INTERMACS annual report: a 10,000-patient database

J Heart Lung Transplant. 2014 Jun;33(6):555-64. doi: 10.1016/j.healun.2014.04.010. Epub 2014 Apr 21.

Abstract

The sixth annual report of the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) summarizes the first 8 years of patient enrollment. The analysis is based on data from >10,000 patients and updates demographics, survival, adverse events and risk factors. Among patients with continuous-flow pumps, actuarial survival continues to be 80% at 1 year and 70% at 2 years. The report features a comparison of two eras of continuous-flow durable devices in the USA in terms of device strategy, patient profiles, adverse event burden, survival and quality of life.

Keywords: INTERMACS; advanced heart failure; destination therapy; mechanical support; ventricular assist device.

MeSH terms

  • Adolescent
  • Adult
  • Child
  • Child, Preschool
  • Databases, Factual*
  • Extracorporeal Circulation / adverse effects
  • Extracorporeal Circulation / instrumentation
  • Extracorporeal Circulation / statistics & numerical data
  • Female
  • Heart Failure / therapy*
  • Heart-Assist Devices / adverse effects
  • Heart-Assist Devices / statistics & numerical data*
  • Humans
  • Infant
  • Male
  • Quality of Life
  • Survival Analysis
  • United States